Your browser doesn't support javascript.
loading
A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in mice.
Mosa, Alexander I; Urbanowicz, Richard A; AbouHaidar, Mounir G; Tavis, John E; Ball, Jonathan K; Feld, Jordan J.
Afiliación
  • Mosa AI; Department of Cell and Systems Biology, University of Toronto, Canada. Electronic address: alexander.mosa@mail.utoronto.ca.
  • Urbanowicz RA; Wolfson Centre for Global Virus Infections, University of Nottingham, UK; School of Life Sciences, University of Nottingham, UK.
  • AbouHaidar MG; Department of Cell and Systems Biology, University of Toronto, Canada.
  • Tavis JE; Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, United States.
  • Ball JK; Wolfson Centre for Global Virus Infections, University of Nottingham, UK; School of Life Sciences, University of Nottingham, UK.
  • Feld JJ; Toronto Centre for Liver Disease, Toronto General Hospital, Sandra Rotman Centre for Global Health, University of Toronto, Canada.
Vaccine ; 38(44): 6864-6867, 2020 10 14.
Article en En | MEDLINE | ID: mdl-32900542

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hepatitis C / Anticuerpos Neutralizantes Límite: Animals Idioma: En Revista: Vaccine Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hepatitis C / Anticuerpos Neutralizantes Límite: Animals Idioma: En Revista: Vaccine Año: 2020 Tipo del documento: Article